Reardon, David A.
Dana-Farber Cancer Institute,
United States
2024 Rank: 15839
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 518 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15839 | 15985 |
| Total Cites | 4434 | 4875 |
| H-index | 28 | 30 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 76 | 76 |
| Total Cites to Single+First Authored Papers | 518 | 557 |
| Number of Single+First+Last Authored Papers | 137 | 137 |
| Total Cites to Single+First+Last Authored Papers | 1057 | 1138 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2809 | 2948 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.65 |
| Self-Citation Percentage |
9.05%
|
|
Reardon, David A.
Dana-Farber Cancer Institute,
United States
2023 Rank: 10654
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 384 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10654 | 11061 |
| Total Cites | 4207 | 4648 |
| H-index | 26 | 29 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 508 | 545 |
| Number of Single+First+Last Authored Papers | 135 | 135 |
| Total Cites to Single+First+Last Authored Papers | 1077 | 1159 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2823 | 2954 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.57 |
| Self-Citation Percentage |
9.49%
|
|
Reardon, David A.
Dana-Farber Cancer Institute,
United States
2022 Rank: 11586
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 443 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11586 | 12314 |
| Total Cites | 4018 | 4350 |
| H-index | 27 | 27 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 74 | 74 |
| Total Cites to Single+First Authored Papers | 513 | 558 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 1098 | 1193 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2680 | 2810 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.55 |
| Self-Citation Percentage |
7.63%
|
|
Reardon, David A.
Dana-Farber Cancer Institute,
United States
2021 Rank: 16858
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 618 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16858 | 17378 |
| Total Cites | 5365 | 5826 |
| H-index | 31 | 33 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 72 | 72 |
| Total Cites to Single+First Authored Papers | 611 | 656 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 1387 | 1497 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3637 | 3807 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.53 |
| Self-Citation Percentage |
7.91%
|
|
Reardon, David A.
Dana-Farber Cancer Institute,
United States
2020 Rank: 22990
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 807 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22990 | 24523 |
| Total Cites | 3270 | 3574 |
| H-index | 22 | 24 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 327 | 343 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 788 | 849 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2346 | 2476 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.44 |
| Self-Citation Percentage |
8.51%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.